Glimepiride Tablets 4 mg Manufacturer in India – Healthy Life Pharma Pvt. Ltd.

Glimepiride Tablets 4 mg | Manufacturer
Product image for Glimepiride Tablets 4 mg Manufacturer; contract manufacturing, oem & quality control.
Product Information
| Generic Name | Glimepiride |
|---|---|
| Manufacturer | Healthy Life Pharma Pvt. Ltd. |
| HSN Code | 30049099 |
| Pharmacopoeia | IP / BP |
| Product Type | Tablet |
| Category | Antidiabetic drugs |
| Subcategory | Antidiabetic drugs |
| Active Ingredient | Glimepiride |
| Strength | 4 mg |
| Dosage Form | Tablet |
| Pack Size | 10 x 10 Tablets / Box (Alu-Alu / Blister) |
| Route of Administration | Oral |
| Prescription Required | Yes |
| Therapeutic Category | Antidiabetic drugs |
Medicine Details & Safety
| Short Description | Healthy Life Pharma invites contract and third-party manufacturing enquiries for Glimepiride Tablets 4 mg from pharmaceutical marketing companies, institutional buyers and brand owners. Production specifications, batch size and packaging are agreed against the approved product dossier and purchase requirements. | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Approved Uses / Indications | 1. Monotherapy as an adjunct to diet and exercise for glycemic control in type 2 diabetes mellitus. 2. Combination therapy with other oral antidiabetic agents or insulin when dual therapy is required. | ||||||||||||||||||||||||
| Full Description | Healthy Life Pharma invites contract and third-party manufacturing enquiries for Glimepiride Tablets 4 mg from pharmaceutical marketing companies, institutional buyers and brand owners. Production specifications, batch size and packaging are agreed against the approved product dossier and purchase requirements. Product technical specifications
Product technical specifications
Manufacturing capabilities and infrastructureFor Glimepiride Tablets 4 mg, assess the approved formulation process, equipment suitability, batch scale and in-process controls for the Tablet presentation. Confirm environmental requirements and validated process before production.Quality control and assuranceRequest the approved finished-product specification for Glimepiride Tablets 4 mg, including applicable identity, assay, uniformity and performance tests for the Tablet presentation. Confirm analytical methods, acceptance criteria and batch release documentation, including COA availability.Primary and secondary packagingThe catalogue pack for Glimepiride Tablets 4 mg is 10 x 10 Tablets / Box (Alu-Alu / Blister). Confirm primary packaging compatibility, stability evidence, artwork, batch coding and leaflet requirements against the approved specification.Contract manufacturing and private labelSubmit the target market, strength, pharmacopoeial specification, forecast volume and brand artwork. Agree feasibility, batch size, quality agreement, production schedule and release criteria before execution. | ||||||||||||||||||||||||
| Dosage Instructions | Administer orally with meals or immediately before food intake as directed by the physician. Recommended dosage should be individualized based on glycemic response and HbA1c targets. Maintain regular blood glucose self-monitoring during initiation and titration. | ||||||||||||||||||||||||
| Side Effects | Common: Mild gastrointestinal discomfort, nausea, flatulence, abdominal fullness, diarrhea. Uncommon: Hypoglycemia (when combined with other antidiabetic agents), transient metallic taste, mild headache. Rare: Skin rash, urticaria, elevated hepatic transaminases. | ||||||||||||||||||||||||
| Warnings and Precautions | Hypoglycemia Risk: Concomitant use with sulfonylureas or insulin secretagogues heightens hypoglycemic risk; ensure immediate access to fast-acting carbohydrates. Renal & Hepatic Monitoring: Periodically assess serum creatinine, eGFR, and liver function tests during long-term therapy. | ||||||||||||||||||||||||
| Contraindications | 1. Known hypersensitivity to Glimepiride or formulation excipients. 2. Diabetic ketoacidosis, hyperosmolar hyperglycemic state, or diabetic coma. 3. Severe renal impairment (eGFR < 30 mL/min) or advanced hepatic insufficiency. 4. Acute metabolic acidosis. | ||||||||||||||||||||||||
| Drug Interactions | 1. Sulfonylureas, Meglitinides & Insulin: Enhanced hypoglycemic effect requiring dose adjustments. 2. Corticosteroids, Thiazides & Sympathomimetics: May attenuate glycemic control, requiring upward titration. 3. Alcohol: May potentiate hypoglycemia or risk of metabolic acidosis. |
Frequently Asked Questions
| Question | Answer |
|---|---|
| Can I request third-party manufacturing for Glimepiride Tablets 4 mg? | Submit your brand, quantity and packaging requirements for manufacturing feasibility review. |
| Which pharmacopoeial standard applies for Glimepiride Tablets 4 mg? | The source specification is IP / BP; confirm the required standard before contracting. |
| What quality tests are applicable for Glimepiride Tablets 4 mg? | Request the approved finished-product specification and batch testing plan. |
| Can packaging be customized for Glimepiride Tablets 4 mg? | Submit artwork and pack requirements for technical and regulatory review. |
| How do I request a manufacturing quotation for Glimepiride Tablets 4 mg? | Provide forecast volume, target market, strength and packaging requirements. |
Related Products
✚
Glimepiride Tablets 1 mg ExporterView product →
✚
Glimepiride Tablets 1 mg ManufacturerView product →
✚
Glimepiride Tablets 1 mg SupplierView product →
✚
Glimepiride Tablets 2 mg ExporterView product →
✚
Glimepiride Tablets 2 mg ManufacturerView product →
✚
Glimepiride Tablets 2 mg SupplierView product →
✚
Glimepiride Tablets 4 mg ExporterView product →
✚
Glimepiride Tablets 4 mg SupplierView product →
✚
Glimepiride Tablets IP 1 mg ExporterView product →
✚
Glimepiride Tablets IP 1 mg ManufacturerView product →
✚
Glimepiride Tablets IP 1 mg SupplierView product →
✚
Glimepiride Tablets IP 2 mg ExporterView product →
Latest Posts
✚
WHO GMP certfied Glibenclamide Metformin SR TabletsRead article →✚
WHO GMP certfied Frusemide Tablets ManufacturerRead article →✚
Folic Acid Niacinamide Tablets ManufacturerRead article →✚
WHO GMP certfied Folic Acid Tablets ManufacturerRead article →✚
WHO GMP certfied Fluconazole Tablets ManufacturerRead article →✚
WHO GMP certfied Ferrous Sulphate with folic acid TabletsRead article →✚
WHO GMP certfied iron with folic acid Tablets ManufacturerRead article →✚
WHO GMP certfied Ferrous Sulphate Tablets ManufacturerRead article →